(Q48535724)

English

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

scientific article published in February 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. (English)

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

progressive supranuclear palsy

1 reference

based on heuristic

inferred from title

striatonigral degeneration

1 reference

based on heuristic

inferred from title

Richard S. J. Frackowiak

10

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

C. David Marsden

8

object named as

Marsden CD

1 reference

Europe PubMed Central

12 February 2018

Andrew John Lees

7

object named as

Lees AJ

1 reference

Europe PubMed Central

12 February 2018

author name string

Brooks DJ

1

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Ibanez V

2

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Sawle GV

3

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Playford ED

4

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Quinn N

5

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Mathias CJ

6

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Bannister R

9

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

publication date

1 February 1992

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Annals of Neurology

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

31

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

184-192

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

2

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410310209

21 January 2018

Identifiers

10.1002/ANA.410310209

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1575457

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48535724&oldid=1524064537"